All lobbying filings

NVG, LLC

Lobbying for ACCENDRA HEALTH INC. FKA OWENS & MINOR, INC. · Global healthcare solutions company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $80,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 3

HR 2902
SOAR Act of 2025
S 1406
SOAR Act of 2025
S 4037
Diabetes Act

Lobbying activity 2

Medicare/Medicaid

Issues related to diabetes management and durable medical equipment reimbursement channels. Issues related to Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Updates and DMEPOS accreditation requirements in DMEPOS Calendar Year 2026 Final Rule. H.R.2902/S.1406 - Supplemental Oxygen Access Reform (SOAR) Act of 2025. S.4037 - Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act.

Budget/Appropriations

Report language for FY2027 Appropriations related to changes in the Competitive Bidding Program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.